Completed
Bortezomib and Low Dose Cytarabine in the Treatment of High-risk Myelodysplastic Syndromes
NCT00411905
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
- Locations
-
- CHU Angers Angers, France
- Hopital Avicenne Bobigny, France
- Institut Bergonie Bordeaux, France
- CHU de Caen Caen, France